Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Jul 13, 2006 by Edgar Snyder

FDA Reevaluates Clinical Drug Trial Standards


After coming under scrutiny for their approval of the antibiotic Ketek, which may cause liver damage in some patients, the Food and Drug Administration (FDA) will reevaluate how they handle clinical drug trials.

The current FDA regulations on clinical drug trials date back over twenty-five years ago when studies were done by a single doctor. These days, trials involve thousands of patients at various locations, and instead of a doctor coordinating the study there are now organized by clinical-research organizations. The FDA believes that regulations should govern all parties involved in a clinical trial.

The FDA is planning to propose a new rule this year that would require study sponsors to report anyone who has committed fraud in a trial.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “FDA Weighs Stiffer Drug-Trial Rules.” By Anna Wilde Mathews. The Wall Street Journal. June 2006.

Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers